Position in NBIX
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$10,351,733
-$1,235,919 QoQ
Shares Held
78,577
-3.8% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99.3522277511231.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6477722488768979.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $85,307,293 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
231,874 | $27,409,824 | |
| 2 | ALKS |
Alkermes plc.
|
378,090 | $13,369,261 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
212,461 | $12,592,562 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
219,099 | $11,325,226 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
78,577 | $10,351,733 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
8,052 | $4,774,674 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
80,571 | $1,928,063 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
53,377 | $1,607,715 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,351,733 | 78,577 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $11,587,652 | 81,701 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $17,123,866 | 154,827 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,298,094 | 163,356 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,182,272 | 10,261 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,526,622 | 11,089 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,786,201 | 12,951 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,733,039 | 13,153 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $340,425 | 3,026 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $873,595 | 9,264 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $937,702 | 9,264 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,009,339 | 16,823 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,093,750 | 10,298 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,468,341 | 15,063 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,576,218 | 16,813 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,840,779 | 21,613 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,057,802 | 31,882 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,438,607 | 35,333 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,487,579 | 35,862 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $3,891,126 | 40,596 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,234,085 | 23,233 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,200,426 | 26,233 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,667,126 | 19,262 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||